HI
CELZ icon

Harbour Investments’s Creative Medical Technology CELZ Stock Holding History

Harbour Investments’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325 Buy
+224
New +$484 ﹤0.01% 4447

Other funds holding CELZ

AFM
Anson Funds Management Dallas, Texas $1.68B AUM 374.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harbour Investments's CELZ Position: Q2 2026 in Review

Harbour Investments opened a new position in Creative Medical Technology (CELZ) in Q2 2026: 224 shares worth $325. The stake represents ﹤0.01% of the portfolio and ranks #4447 among its holdings.

14 funds tracked by Wall St. Rank hold CELZ as of Q2 2026.

  • Harbour Investments held 224 shares of Creative Medical Technology worth $325 as of Q2 2026.
  • Creative Medical Technology was a new Harbour Investments position in Q2 2026.
  • Creative Medical Technology made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4447 holding.
  • 14 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.